Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POTE ankyrin domain family member F (POTEF) is a primate-specific member of the POTE ankyrin domain-containing gene family. Its protein product is a chimeric molecule that includes ankyrin repeat domains and an acquired β-actin domain due to retrotransposition, resulting in high homology with the related protein POTEE[3][5]. POTEF is predicted to function in protein kinase binding and as a structural constituent of the postsynaptic actin cytoskeleton, with roles in axonogenesis and cell motility[1][2][6]. Its expression is found in tissues such as ovary, testis, and many cancers, and it localizes to the cytoskeleton near the inner plasma membrane[1][3]. POTEF has been shown to interact with the chaperonin containing TCP-1 complex (CCT), impacting cell proliferation and possibly contributing to cell death through a mitochondrial-dependent apoptotic pathway, especially when overexpressed[1][3]. Overaccumulation may result in autophagic failure in granulosa cells, which is linked to follicular atresia and primary ovarian insufficiency[3]. POTEF is not a classical therapeutic target such as a receptor, enzyme, or transporter, but it is of interest due to its roles in apoptosis, cell proliferation, and as a potential autoantigen in ovarian autoimmunity and some cancers[3][1][2]. There are currently no known drugs targeting POTEF, and it is not established as a clinically actionable biomarker or therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POTE ankyrin domain family member F (POTEF).